RIBOCICLIB-TABLETTE

Patent europeic · EP4197530 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4197530
Numer da la dumonda
EP22203730
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-04-2016
Publitgà
21-06-2023
Concedì
12-11-2025
La protecziun finescha il pli tard
13-04-2036
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
A61K 9/20 (2006.01)
Prioritad
US 201562148240 P 16.04.2015
Derivà da
EP16718020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-08-2026

    Midada

    Published in Swissreg on 19.08.2026

  2. 19-08-2026

    Midada

    Published in Swissreg on 19.08.2026

  3. 19-08-2026

    Midada

    Published in Swissreg on 19.08.2026

  4. 01-05-2026

    Next annual fee due on

    Next annual fee due on
    30.04.2026 → 30.04.2027

    Published in Swissreg on 01.05.2026

  5. 12-11-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 12.11.2025

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

GURURAJAN, Bindhumadhavan

4002 Basel

GRANDEURY, Arnaud

4002 Basel

COSTA, Rui

4002 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.